Disulfide bond structures of IgG molecules

References

• Milstein C. The disulphide bridges of immunoglobulin kappa-chains. Biochem J 1966; 101:338 - 351; PMID: 4165119
   PubMed Web of Science ®Google Scholar
• Pink JR, Milstein C. Inter heavy-light chain disulphide bridge in immune globulins. Nature 1967; 214:92 - 94; PMID: 4166384; http://dx.doi.org/10.1038/214092a0
   PubMed Web of Science ®Google Scholar
• Frangione B, Milstein C. Disulphide bridges of immunoglobin G-1 heavy chains. Nature 1967; 216:939 - 941; PMID: 4169396; http://dx.doi.org/10.1038/216939b0
   PubMed Web of Science ®Google Scholar
• Pink JR, Milstein C. Disulphide bridges of a human immunoglobulin G protein. Nature 1967; 216:941 - 942; PMID: 4169397; http://dx.doi.org/10.1038/216941a0
   PubMed Web of Science ®Google Scholar
• Frangione B, Milstein C, Franklin EC. Intrachain disulphide bridges in immunoglobulin G heavy chains. The Fc fragment. Biochem J 1968; 106:15 - 21; PMID: 4889360
   PubMed Web of Science ®Google Scholar
• Frangione B, Milstein C. Variations in the S-S bridges of immunoglobins G: interchain disulfide bridges of gammaG3 myeloma proteins. J Mol Biol 1968; 33:893 - 906; PMID: 4178186; http://dx.doi.org/10.1016/0022-2836(68)90326-4
   PubMedGoogle Scholar
• Edelman GM, Cunningham BA, Gall WE, Gottlieb PD, Rutishauser U, Waxdal MJ. The covalent structure of an entire gammaG immunoglobulin molecule. Proc Natl Acad Sci USA 1969; 63:78 - 85; PMID: 5257969; http://dx.doi.org/10.1073/pnas.63.1.78
   PubMed Web of Science ®Google Scholar
• Frangione B, Milstein C, Pink JR. Structural studies of immunoglobulin G. Nature 1969; 221:145 - 148; PMID: 5782707; http://dx.doi.org/10.1038/221145a0
   PubMed Web of Science ®Google Scholar
• Lefranc MP, Pommie C, Kaas Q, Duprat E, Bosc N, Guiraudou D, et al. IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. Dev Comp Immunol 2005; 29:185 - 203; PMID: 15572068; http://dx.doi.org/10.1016/j.dci.2004.07.003
   PubMed Web of Science ®Google Scholar
• Lefranc MP, Pommie C, Ruiz M, Giudicelli V, Foulquier E, Truong L, et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 2003; 27:55 - 77; PMID: 12477501; http://dx.doi.org/10.1016/S0145-305X(02)00039-3
   PubMed Web of Science ®Google Scholar
• Amzel LM, Poljak RJ. Three-dimensional structure of immunoglobulins. Annu Rev Biochem 1979; 48:961 - 997; PMID: 89832; http://dx.doi.org/10.1146/annurev.bi.48.070179.004525
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Goto Y, Hamaguchi K. Reduction of the buried intrachain disulfide bond of the constant fragment of the immunoglobulin light chain: global unfolding under physiological conditions. Biochemistry 1986; 25:2009 - 2013; PMID: 3085710; http://dx.doi.org/10.1021/bi00356a026
   PubMed Web of Science ®Google Scholar
• Bloom JW, Madanat MS, Marriott D, Wong T, Chan SY. Intrachain disulfide bond in the core hinge region of human IgG4. Protein Sci 1997; 6:407 - 415; PMID: 9041643; http://dx.doi.org/10.1002/pro.5560060217
   PubMed Web of Science ®Google Scholar
• Wypych J, Li M, Guo A, Zhang Z, Martinez T, Allen MJ, et al. Human IgG2 antibodies display disulfide-mediated structural isoforms. J Biol Chem 2008; 283:16194 - 16205; PMID: 18339624; http://dx.doi.org/10.1074/jbc.M709987200
   PubMed Web of Science ®Google Scholar
• Dillon TM, Ricci MS, Vezina C, Flynn GC, Liu YD, Rehder DS, et al. Structural and functional characterization of disulfide isoforms of the human IgG2 subclass. J Biol Chem 2008; 283:16206 - 16215; PMID: 18339626; http://dx.doi.org/10.1074/jbc.M709988200
   PubMed Web of Science ®Google Scholar
• Martinez T, Guo A, Allen MJ, Han M, Pace D, Jones J, et al. Disulfide connectivity of human immunoglobulin G2 structural isoforms. Biochemistry 2008; 47:7496 - 7508; PMID: 18549248; http://dx.doi.org/10.1021/bi800576c
   PubMed Web of Science ®Google Scholar
• Liu YD, Chen X, Enk JZ, Plant M, Dillon TM, Flynn GC. Human IgG2 antibody disulfide rearrangement in vivo. J Biol Chem 2008; 283:29266 - 29272; PMID: 18713741; http://dx.doi.org/10.1074/jbc.M804787200
   PubMed Web of Science ®Google Scholar
• Wang X, Kumar S, Singh S. Disulfide bond scrambling in IgG2 monoclonal antibodies: insights from molecular dynamics simulations. Pharm Res 2011; http://dx.doi.org/10.1007/s11095-011-0503-9; PMID: 21671135
   PubMed Web of Science ®Google Scholar
• Yoo EM, Wims LA, Chan LA, Morrison SL. Human IgG2 can form covalent dimers. J Immunol 2003; 170:3134 - 3138; PMID: 12626570
   PubMed Web of Science ®Google Scholar
• Petersen JG, Dorrington KJ. An in vitro system for studying the kinetics of interchain disulfide bond formation in immunoglobulin G. J Biol Chem 1974; 249:5633 - 5641; PMID: 4212934
   PubMed Web of Science ®Google Scholar
• Colcher D, Milenic D, Roselli M, Raubitschek A, Yarranton G, King D, et al. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Cancer Res 1989; 49:1738 - 1745; PMID: 2924317
   PubMed Web of Science ®Google Scholar
• King DJ, Adair JR, Angal S, Low DC, Proudfoot KA, Lloyd JC, et al. Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment. Biochem J 1992; 281:317 - 323; PMID: 1736881
   PubMed Web of Science ®Google Scholar
• Angal S, King DJ, Bodmer MW, Turner A, Lawson AD, Roberts G, et al. A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Mol Immunol 1993; 30:105 - 108; PMID: 8417368; http://dx.doi.org/10.1016/0161-5890(93)90432-B
   PubMed Web of Science ®Google Scholar
• Schuurman J, Perdok GJ, Gorter AD, Aalberse RC. The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds. Mol Immunol 2001; 38:1 - 8; PMID: 11483205; http://dx.doi.org/10.1016/S0161-5890(01)00050-5
   PubMed Web of Science ®Google Scholar
• van der Zee JS, van Swieten P, Aalberse RC. Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J Immunol 1986; 137:3566 - 3571; PMID: 3782791
   PubMed Web of Science ®Google Scholar
• Schuurman J, Van Ree R, Perdok GJ, Van Doorn HR, Tan KY, Aalberse RC. Normal human immunoglobulin G4 is bispecific: it has two different antigen-combining sites. Immunology 1999; 97:693 - 698; PMID: 10457225; http://dx.doi.org/10.1046/j.1365-2567.1999.00845.x
   PubMed Web of Science ®Google Scholar
• van der NeutKolfschoten M, Schuurman J, Losen M, Bleeker WK, Martinez-Martinez P, Vermeulen E, et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007; 317:1554 - 1557; PMID: 17872445; http://dx.doi.org/10.1126/science.1144603
   PubMed Web of Science ®Google Scholar
• Schauenstein E, Sorger S, Reiter M, Dachs F. Free thiol groups and labile disulfide bonds in the IgG fraction of human serum. J Immunol Methods 1982; 50:51 - 56; PMID: 7086149; http://dx.doi.org/10.1016/0022-1759(82)90303-9
   PubMed Web of Science ®Google Scholar
• Schauenstein E, Dachs F, Reiter M, Gombotz H, List W. Labile disulfide bonds and free thiol groups in human IgG. I. Assignment to IgG1 and IgG2 subclasses. Int Arch Allergy Appl Immunol 1986; 80:174 - 179; PMID: 3710611; http://dx.doi.org/10.1159/000234048
   PubMedGoogle Scholar
• Gevondyan NM, Volynskaia AM, Gevondyan VS. Four free cysteine residues found in human IgG1 of healthy donors. Biochemistry (Mosc) 2006; 71:279 - 284; PMID: 16545064; http://dx.doi.org/10.1134/S0006297906030072
   PubMed Web of Science ®Google Scholar
• Lacy ER, Baker M, Brigham-Burke M. Free sulfhydryl measurement as an indicator of antibody stability. Anal Biochem 2008; 382:66 - 68; PMID: 18675772; http://dx.doi.org/10.1016/j.ab.2008.07.016
   PubMed Web of Science ®Google Scholar
• Zhang W, Czupryn MJ. Free sulfhydryl in recombinant monoclonal antibodies. Biotechnol Prog 2002; 18:509 - 513; PMID: 12052067; http://dx.doi.org/10.1021/bp025511z
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Chumsae C, Newby-Kew A. Characterization of lower molecular weight artifact bands of recombinant monoclonal IgG1 antibodies on non-reducing SDS-PAGE. Biotechnol Lett 2007; 29:1611 - 1622; PMID: 17609855; http://dx.doi.org/10.1007/s10529-007-9449-8
   PubMed Web of Science ®Google Scholar
• Brych SR, Gokarn YR, Hultgen H, Stevenson RJ, Rajan R, Matsumura M. Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation. J Pharm Sci 2010; 99:764 - 781; PMID: 19691118
   PubMed Web of Science ®Google Scholar
• Franey H, Brych SR, Kolvenbach CG, Rajan RS. Increased aggregation propensity of IgG2 subclass over IgG1: role of conformational changes and covalent character in isolated aggregates. Protein Sci 2010; 19:1601 - 1615; PMID: 20556807; http://dx.doi.org/10.1002/pro.434
   PubMed Web of Science ®Google Scholar
• Chumsae C, Gaza-Bulseco G, Liu H. Identification and localization of unpaired cysteine residues in monoclonal antibodies by fluorescence labeling and mass spectrometry. Anal Chem 2009; 81:6449 - 6457; PMID: 19572546; http://dx.doi.org/10.1021/ac900815z
   PubMed Web of Science ®Google Scholar
• Xiang T, Chumsae C, Liu H. Localization and quantitation of free sulfhydryl in recombinant monoclonal antibodies by differential labeling with 12C and 13C iodoacetic acid and LC-MS analysis. Anal Chem 2009; 81:8101 - 8108; PMID: 19722496; http://dx.doi.org/10.1021/ac901311y
   PubMed Web of Science ®Google Scholar
• Harris RJ. Heterogeneity of recombinant antibodies: linking structure to function. Dev Biol (Basel) 2005; 122:117 - 127; PMID: 16375256
   PubMedGoogle Scholar
• Ouellette D, Alessandri L, Chin A, Grinnell C, Tarcsa E, Radziejewski C, et al. Studies in serum support rapid formation of disulfide bond between unpaired cysteine residues in the VH domain of an immunoglobulin G1 molecule. Anal Biochem 2010; 397:37 - 47; PMID: 19766583; http://dx.doi.org/10.1016/j.ab.2009.09.027
   PubMed Web of Science ®Google Scholar
• Chaderjian WB, Chin ET, Harris RJ, Etcheverry TM. Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed. Biotechnol Prog 2005; 21:550 - 553; PMID: 15801797; http://dx.doi.org/10.1021/bp0497029
   PubMed Web of Science ®Google Scholar
• Nashef AS, Osuga DT, Lee HS, Ahmed AI, Whitaker JR, Feeney RE. Effects of alkali on proteins. Disulfides and their products. J Agric Food Chem 1977; 25:245 - 251; PMID: 838959; http://dx.doi.org/10.1021/mjf60210a020
   PubMed Web of Science ®Google Scholar
• Florence TM. Degradation of protein disulphide bonds in dilute alkali. Biochem J 1980; 189:507 - 520; PMID: 7213343
   PubMed Web of Science ®Google Scholar
• Galande AK, Trent JO, Spatola AF. Understanding base-assisted desulfurization using a variety of disulfide-bridged peptides. Biopolymers 2003; 71:534 - 551; PMID: 14635094; http://dx.doi.org/10.1002/bip.10532
   PubMed Web of Science ®Google Scholar
• Tous GI, Wei Z, Feng J, Bilbulian S, Bowen S, Smith J, et al. Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains. Anal Chem 2005; 77:2675 - 2682; PMID: 15859580; http://dx.doi.org/10.1021/ac0500582
   PubMed Web of Science ®Google Scholar
• Cohen SL, Price C, Vlasak J. Beta-elimination and peptide bond hydrolysis: two distinct mechanisms of human IgG1 hinge fragmentation upon storage. J Am Chem Soc 2007; 129:6976 - 6977; PMID: 17500521; http://dx.doi.org/10.1021/ja0705994
   PubMed Web of Science ®Google Scholar
• Pristatsky P, Cohen SL, Krantz D, Acevedo J, Ionescu R, Vlasak J. Evidence for trisulfide bonds in a recombinant variant of a human IgG2 monoclonal antibody. Anal Chem 2009; 81:6148 - 6155; PMID: 19591437; http://dx.doi.org/10.1021/ac9006254
   PubMed Web of Science ®Google Scholar
• Gu S, Wen D, Weinreb PH, Sun Y, Zhang L, Foley SF, et al. Characterization of trisulfide modification in antibodies. Anal Biochem 2010; 400:89 - 98; PMID: 20085742; http://dx.doi.org/10.1016/j.ab.2010.01.019
   PubMed Web of Science ®Google Scholar
• Nielsen RW, Tachibana C, Hansen N, Winther J. Trisulfides in proteins. Antioxid Redox Signal 2011; 15:67 - 75; PMID: 20977350; http://dx.doi.org/10.1089/ars.2010.3677
   PubMed Web of Science ®Google Scholar
• McAuley A, Jacob J, Kolvenbach CG, Westland K, Lee HJ, Brych SR, et al. Contributions of a disulfide bond to the structure, stability and dimerization of human IgG1 antibody CH3 domain. Protein Sci 2008; 17:95 - 106; PMID: 18156469; http://dx.doi.org/10.1110/ps.073134408
   PubMed Web of Science ®Google Scholar
• Thies MJ, Mayer J, Augustine JG, Frederick CA, Lilie H, Buchner J. Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization. J Mol Biol 1999; 293:67 - 79; PMID: 10512716; http://dx.doi.org/10.1006/jmbi.1999.3128
   PubMed Web of Science ®Google Scholar
• Proba K, Honegger A, Pluckthun A. A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding. J Mol Biol 1997; 265:161 - 172; PMID: 9020980; http://dx.doi.org/10.1006/jmbi.1996.0726
   PubMed Web of Science ®Google Scholar
• Burton DR. Immunoglobulin G: functional sites. Mol Immunol 1985; 22:161 - 206; PMID: 3889592; http://dx.doi.org/10.1016/0161-5890(85)90151-8
   PubMed Web of Science ®Google Scholar
• Rudikoff S, Pumphrey JG. Functional antibody lacking a variable-region disulfide bridge. Proc Natl Acad Sci USA 1986; 83:7875 - 7878; PMID: 3094016; http://dx.doi.org/10.1073/pnas.83.20.7875
   PubMed Web of Science ®Google Scholar
• Goto Y, Hamaguchi K. The role of the intrachain disulfide bond in the conformation and stability of the constant fragment of the immunoglobulin light chain. J Biochem 1979; 86:1433 - 1441; PMID: 118170
   PubMed Web of Science ®Google Scholar
• Dorrington KJ, Smith BR. Conformational changes accompanying the dissociation and association of immunoglobulin-G subunits. Biochim Biophys Acta 1972; 263:70 - 81; PMID: 5013292
   PubMed Web of Science ®Google Scholar
• Chan LM, Cathou RE. The role of the inter-heavy chain disulfide bond in modulating the flexibility of immunoglobulin G antibody. J Mol Biol 1977; 112:653 - 656; PMID: 406410; http://dx.doi.org/10.1016/S0022-2836(77)80170-8
   PubMed Web of Science ®Google Scholar
• Olins DE, Edelman GM. Reconstitution of 7S molecules from L and H polypeptide chains of antibody and gamma-globulins. J Exp Med 1964; 119:789 - 815; PMID: 14157031; http://dx.doi.org/10.1084/jem.119.5.789
   PubMed Web of Science ®Google Scholar
• Björk I, Tanford C. Recovery of native conformation of rabbit immunoglobulin G upon recombination of separately renatured heavy and light chains at near-neutral pH. Biochemistry 1971; 10:1289 - 1295; PMID: 4996348; http://dx.doi.org/10.1021/bi00784a003
   PubMed Web of Science ®Google Scholar
• Michaelsen TE, Naess LM, Aase A. Human IgG3 is decreased and IgG1, IgG2 and IgG4 are unchanged in molecular size by mild reduction and reoxidation without any major change in effector functions. Mol Immunol 1993; 30:35 - 45; PMID: 8417373; http://dx.doi.org/10.1016/0161-5890(93)90424-A
   PubMed Web of Science ®Google Scholar
• Seegan GW, Smith CA, Schumaker VN. Changes in quaternary structure of IgG upon reduction of the interheavy-chain disulfide bond. Proc Natl Acad Sci USA 1979; 76:907 - 911; PMID: 106398; http://dx.doi.org/10.1073/pnas.76.2.907
   PubMed Web of Science ®Google Scholar
• Michaelsen TE. Alteration of the conformation of human IgG subclasses by reduction of the hinge S-S bonds. Mol Immunol 1988; 25:639 - 646; PMID: 3419438; http://dx.doi.org/10.1016/0161-5890(88)90099-5
   PubMed Web of Science ®Google Scholar
• Johnson BA, Hoffmann LG. Effect of reduction and alkylation on structure and function of rabbit IgG antibody-I. Effect on ability to activate complement depends on conditions of reduction. Mol Immunol 1981; 18:181 - 188; PMID: 7266486; http://dx.doi.org/10.1016/0161-5890(81)90084-5
   PubMed Web of Science ®Google Scholar
• Goers JW, Ziccardi RJ, Schumaker VN, Glovsky MM. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex. J Immunol 1977; 118:2182 - 2191; PMID: 559020
   PubMed Web of Science ®Google Scholar
• Schur PH, Christian GD. The role of disulfide bonds in the complement-fixing and precipitating properties of 7S rabbit and sheep antibodies. J Exp Med 1964; 120:531 - 545; PMID: 14212117; http://dx.doi.org/10.1084/jem.120.4.531
   PubMed Web of Science ®Google Scholar
• Press EM. Fixation of the first component of complement by immune complexes: effect of reduction and fragmentation of antibody. Biochem J 1975; 149:285 - 288; PMID: 1238086
   PubMed Web of Science ®Google Scholar
• Isenman DE, Dorrington KJ, Painter RH. The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement. J Immunol 1975; 114:1726 - 1729; PMID: 1127227
   PubMed Web of Science ®Google Scholar
• Klein M, Neauport-Sautes C, Ellerson JR, Fridman WH. Binding site of human IgG subclasses and their domains for Fc receptors of activated murine T cells. J Immunol 1977; 119:1077 - 1083; PMID: 330745
   PubMed Web of Science ®Google Scholar
• McNabb T, Koh TY, Dorrington KJ, Painter RH. Structure and function of immunoglobulin domains. V. Binding, University of immunoglobulin G and fragments to placental membrane preparations. J Immunol 1976; 117:882 - 888; PMID: 956658
   PubMed Web of Science ®Google Scholar
• Michaelsen TE, Wisloff F, Natvig JB. Structural requirements in the Fc region of rabbit IgG antibodies necessary to induce cytotoxicity by human lymphocytes. Scand J Immunol 1975; 4:71 - 78; PMID: 1079629; http://dx.doi.org/10.1111/j.1365-3083.1975.tb02601.x
   PubMed Web of Science ®Google Scholar
• Barnett Foster DE, Dorrington KJ, Painter RH. Structure and function of immunoglobulin domains. VII. Studies on the structural requirements of human immunoglobulin G for granulocyte binding. J Immunol 1978; 120:1952 - 1956; PMID: 659887
   PubMed Web of Science ®Google Scholar
• Liu H, Chumsae C, Gaza-Bulseco G, Hurkmans K, Radziejewski CH. Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation and LC-MS analysis. Anal Chem 2010; 82:5219 - 5226; PMID: 20491447; http://dx.doi.org/10.1021/ac100575n
   PubMed Web of Science ®Google Scholar
• Remmele RL Jr, Callahan WJ, Krishnan S, Zhou L, Bondarenko PV, Nichols AC, et al. Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate. J Pharm Sci 2006; 95:126 - 145; PMID: 16315222; http://dx.doi.org/10.1002/jps.20515
   PubMed Web of Science ®Google Scholar
• Van Buren N, Rehder D, Gadgil H, Matsumura M, Jacob J. Elucidation of two major aggregation pathways in an IgG2 antibody. J Pharm Sci 2009; 98:3013 - 3030; PMID: 18680168; http://dx.doi.org/10.1002/jps.21514
   PubMed Web of Science ®Google Scholar